The histone lysine demethylase KDM4A serves as a coactivator for E2F1, binding to the promoters of PDK1 and PDK3, thus influencing the metabolic transition between glycolysis and mitochondrial oxidation in prostate cancer.36 This evidence concerns the gene E2F1 and prostate cancer.